The trademark application RISEDROCAD was filed by Christoph Karl, a national of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on September 17, 2023, and it was registered by office on December 28, 2023 without any oppositions.
It was designated 'Basic Application' for International Application 1776453 at the World Intellectual Property Organization (WIPO).
The application was filed in German (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on March 3, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals, Especially, Pharmaceutical preparations for the prevention and treatment of bone diseases
Chemicals for medical use, Especially, Chemicals for the prevention and treatment of bone diseases
Biotechnology products for medical use
Medicines for human purposes
Tablets, Capsules, Lozenges, Granules for pharmaceutical purposes
Ointments for pharmaceutical purposes
Injection solutions, for pharmaceutical purposes
Dietetic substances adapted for human medical use
Health foods for medical purposes
Medicinal drinks
Nutritional supplements, In particular for medical purposes
Vitamin and multi-vitamin preparations, In particular for medical purposes
Minerals and mineral preparations, In particular for medical purposes
Biological preparations, Chemical formulations, For medical purposes, in relation to the following fields, Laboratories, Pharmacies, medical practices
Chemical testing agents for medical purposes, in particular reagents, mass solutions, indicators and nutritive media
Filled ready-to-use syringes.
The mark was filed in class 10 with following description of goods:
Surgical, medical and dental instruments and apparatus
Bottles, For infusion purposes
Medical analytical apparatus for medical purposes.
The mark was filed in class 16 with Printed matter, namely Brochures for patients, advertising in magazines and advertising for pharmacists and doctors, all the aforesaid in connection with the prevention and treatment of bone diseases.